Day 1 Afternoon June 25, 2010	09:00-11:30	Opening Ceremony and Keynote Forum
		Hall A	Hall E		Hall F	Hall G	Hall H	Hall J		Hall K
Day 1 Afternoon June 25, 2010	13:10-14:50	1-1	1-2		2-2	3-6	4-3	4-4		5-2
	14:50-15:05	Coffee Break
	15:05-17:10	1-3	1-2		2-3	2-4	4-1	4-4		1-7 1-8
	18:30-20:30	Gala Dinner
Day 2 Morning June 26, 2010	08:30-10:10	1-5	1-6		5-5	3-7 3-8	3-11	4-8		4-9
	10:10-10:25	Coffee Break
	10:25-12:00	1-5	1-6		5-5	3-9	3-11 3-12	4-8		3-15
	12:00-13:00	Lunch Showcase
Day 2 Afternoon June 26, 2010	13:10-14:50	1-9		2-10	3-1	3-18	5-4	5-6		5-7
	14:50-15:05	Coffee Break
	15:05-17:10	1-10	2-7 2-8		3-1	3-18	5-4	3-10		5-8
Day 3 Morning June 27, 2010	08:30-10:10	1-11	1-13		2-11	2-12	3-2	5-1		5-13
	10:10-10:25	Coffee Break
	10:25-12:00	1-12	1-13		5-12	3-3	3-2	5-1	5-13
	12:00-13:00	Industry Lunch Showcase
Day 3 Afternoon June 27, 2010	13:10-14:50	2-5	3-5		4-2	4-5	4-6	5-3		5-10
	14:50-15:05	Coffee Break
	15:05-17:10	2-5 2-6	2-9		4-2	4-5	4-6	5-3 3-4		5-10
Day 4 Morning June 28, 2010	08:30-10:10	1-4	2-1		3-14	3-16	3-13	4-7		5-11
	10:10-10:25	Coffee Break
	10:25-12:00	5-9	2-1		3-14	3-16	3-17	4-10
	12:00-13:00	Lunch Showcase

Track 1: Basic Research of Neurosciences
Track 1-1: The Latest Breaking Neurosciences
Track 1-2: Cellular and Molecular Neuroscience
Track 1-3: Neurogenetics and Neurogenomics
Track 1-4  Neuroeconomics
Track 1-5: Cell Biology of Neurons and Glia Cells  
Track 1-6: Neural Development and Plasticity
Track 1-7: Neuroengineering
Track 1-8: Heat Shock Proteins and Neurodegenerative Diseases
Track 1-9: Neuropsychiatric Biomarkers, Endophenotypes and Genes
Track 1-10: Neuroimmunology, Virology, and Neuro-Oncology
Track 1-11: Integrative Neuroscience
Track 1-12: Epilepsy/EEG
Track 1-13: Neurochemistry & Neuroendocrinology

Track 2: Novel Technologies & Medical Devices for Neural Disorders
Track 2-1: Myelography, Thermography and Ultrasound Imaging Technologies
Track 2-2: Microarray Technologies in Diagnosis of Neurodegenerative Diseases
Track 2-3: Neuromathematics, Neurophysics, Neuroinformatics and Computation Neurobiology
Track 2-4: Functional and Molecular and Cellular Imaging
Track 2-5: Magnetic Resonance Imaging (MRI)
Track 2-6 : Laser Capture Microdissection Technologies
Track 2-7: Brain Scan Technologies
Track 2-8: Computed Tomography
Track 2-9: Positron Emission Tomography (PET) & Single Photon Emission Computed Tomography (SPECT)
Track 2-10: Cerebrospinal Fluid Analytical Technologies
Track 2-11: Electroencephalography, Electromyography, and Electronystagmography
Track 2-12: Evoked Potentials Technologies

Track 3: Medical Research of Neurodegenerative Diseases
Track 3-1: Huntington Disease & Multiple Sclerosis
Track 3-2: Amyotrophic Lateral Sclerosis
Track 3-3: Prion Diseases and Neurosciences
Track 3-4: Attention Deficit Hyperactivity Disorder
Track 3-5: Traumatic Brain Injury
Track 3-6: Endovascular Neurology
Track 3-7: Nervous System Development
Track 3-8: Development of Neuropsychology
Track 3-9: Neuropathic Pains, Mechanism and Advances in Headache
Track 3-10: Aging, Dementia and Stroke and Repair
Track 3-11: Neurogenic Bladder Dysfunction
Track 3-12: Motor Neuromuscular System and Movement Disorders
Track 3-13: Autonomic Disorders
Track 3-14: Repair and Neural Plasticity
Track 3-15: Neuropathology, Neurohistology and Neuropathies
Track 3-16: Nervous System Surgery
Track 3-17: Addictions and Neurosciences
Track 3-18: Alzheimer's Disease

Track 4: Anti-Neurodegenerative Drug Discovery & Development
Track 4-1: Target Validations for Neural Disorders
Track 4-2: Major Neural Disease: Alzheimer' s Disease Drug Discovery
Track 4-3: Neuropharmacology, ADME/T in Anti-Neurodegenerative Drug Discovery
Track 4-4: Ion Channels, Transporters and Neurotransmitter Receptors
Track 4-5: Major Neural Disease: Parkinson' s Disease Drug Discovery
Track 4-6: Major Neural Diseases: Epilepsy, Multiple Sclerosis, Amyotrophic Lateral Sclerosis Drug Discovery
Track 4-7: Animals In Neurologic Research
Track 4-8: Neural Stem Cells and Gene or Cell Therapy
Track 4-9: Monoclonal Antibodies for Neurodegenerative Diseases
Track 4-10: Clinical Trials In Neuroscience

Track 5: Diagnostics, Therapeutics and Clinical Management of Major Neurological Disorders
Track 5-1: Epilepsy
Track 5-2: Laboratory Screening Tests and Genetic Testing for Neurological Disorders
Track 5-3: Anxiety
Track 5-4: Practical and Novel Neurological Examinations
Track 5-5: Diagnostic Tests for Common Neurological Disorders
Track 5-6: Depression
Track 5-7: Insomnia
Track 5-8: Schizophrenia
Track 5-9: Hemispatial Neglect
Track 5-10: Agnosias, Aphasias, Apraxias, Dyslexias
Track 5-11: Neural Repair and Neurorehabilitation
Track 5-12: Amnesias
Track 5-13: Dementias